p. 89-98
VEGF165 is necessary to the metastatic potential of Fas- osteosarcoma cells but will not rescue the Fas+ cells
Shu-Fang Jia, Hui Guan, Xiaoping Duan and Eugenie S. Kleinerman
Abstract
Full Text (IP)
p. 99-112
Cytotoxic and apoptotic effects of bortezomib and gefitinib compared to alk ylating agents on human glioblastoma cells
Stéphane Pédeboscq, Béatrice L’Azou, Isabelle Passagne, Francesca De Giorgi, François Ichas, Jean-Paul Pometan and Jean Cambar
Abstract
Full Text (IP)
p. 113-122
Antitumor activity of two derivatives from 2-acylamine-1, 4-naphthoquinone 113 in mice bearing S180 tumor
Daniel Pereira Bezerra, Ana Paula Negreiros Nunes Alves, Nylane Maria Nunes de Alencar, Rodney de Oliveira Mesquita, Michael Will Lima, Cláudia Pessoa, Manoel Odorico de Moraes, José Norberto Callegari Lopes, Norberto Peporine Lopes and Letícia Veras Costa-Lotufo
Abstract
Full Text (IP)
p. 123-134
Vesicular flavonoid in combating diethylnitrosamine induced hepatocarcinoma in rat model
Ardhendu K. Mandal, Sanchari Das, Maitreyi Mitra, Rohini N. Chakrabarti, Malay Chatterjee and Nirmalendu Das
Abstract
Full Text (IP)
p. 135-146
Bortezomib as a therapeutic candidate for neuroblastoma
Michael B. Armstrong, Kurt R. Schumacher, Rajen Mody, Gregory A. Yanik, Anthony W. Opipari, Jr., and Valerie P. Castle
Abstract
Full Text (IP)
p. 147-152
Mushroom polysaccharide extracts delay progression of carcinogenesis in mice
Carolyne G.O. Wasonga, Sheila A. Okoth, Joseph C. Mukuria and Charles O.A. Omwandho
Abstract
Full Text (IP)
p. 153-168
Nrf2-dependent induction of human ABC transporter ABCG2 and heme 153 oxygenase-1 in HepG2 cells by photoactivation of porphyrins:
biochemical implications for cancer cell response to photodynamic therapy
Yuichiro Hagiya, Tatsuhiko Adachi, Shun-Ichiro Ogura, Ran An, Ai Tamura, Hiroshi Nakagawa, Ichiro Okura, Tohru Mochizuki, and Toshihisa Ishikawa
Abstract
Full Text (IP)
p. 169-171
Conferences / Meetings
Full Text (IP)